David Charles Lubner Insider Trading
Get free email notifications about insider trading for David Charles Lubner.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Charles Lubner. David Charles Lubner is a SVP and CFO in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and a EVP & CFO in Ra Pharmaceuticals, Inc. ($RARX) and an Executive V.P. & CFO in Ra Pharmaceuticals, Inc. ($RARX) and an Executive VP and CFO in Ra Pharmaceuticals, Inc. ($RARX) and a Director in Nightstar Therapeutics plc ($NITE) and a Director in Vor Biopharma Inc. ($VOR) and a Director in Gemini Therapeutics, Inc. /DE ($FSDC) and a Director in Dyne Therapeutics, Inc. ($DYN).
Address: 480 ARSENAL ST. SUITE 110 WATERTOWN 02472 MA
Companies in which David Charles Lubner is an Insider
Dyne Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Charles Lubner: Director
Holdings: 53,625 shares
Latest Transaction: May 27 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Gemini Therapeutics, Inc. /DE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Charles Lubner: Director
Holdings: 0 shares
Latest Transaction: Apr 07 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nightstar Therapeutics plc
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of David Charles Lubner: Director
Holdings: 0 shares
Latest Transaction: Jun 07 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ra Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Charles Lubner: Executive VP and CFO, Executive V.P. & CFO, EVP & CFO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 03 2020
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TETRAPHASE PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Charles Lubner: SVP and CFO
Holdings: 69,270 shares
Current Value: $289,549
Latest Transaction: Aug 17 2015
$TTPH Market Capitalization: $155.73M
$TTPH Previous Close: $4.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vor Biopharma Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of David Charles Lubner: Director
Holdings: 0 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of David Charles Lubner
Sentiment: All, DYN, FSDC, NITE, RARX, TTPH, VOR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2021 | DYN | Dyne Therapeutics, ... | Lubner David Charles | Director | Option Exercise | A | 19.56 | 19,596 | 383,298 | 19,596 | |
| Apr 07 2021 | FSDC | Gemini Therapeutic ... | Lubner David Charles | Director | Option Exercise | A | 12.66 | 58,855 | 745,104 | 58,855 | |
| Mar 15 2021 | FSDC | Gemini Therapeutic ... | Lubner David Charles | Director | Option Exercise | A | 17.00 | 25,000 | 425,000 | 25,000 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Lubner David Charles | Director | Option Exercise | A | 18.00 | 16,900 | 304,200 | 16,900 | |
| Sep 23 2020 | DYN | Dyne Therapeutics, ... | Lubner David Charles | Director | Option Exercise | C | 0.00 | 177,872 | 0 | 0 | |
| Sep 23 2020 | DYN | Dyne Therapeutics, ... | Lubner David Charles | Director | Option Exercise | P | 0.00 | 177,872 | 0 | 177,872 | |
| Sep 23 2020 | DYN | Dyne Therapeutics, ... | Lubner David Charles | Director | Option Exercise | A | 5.54 | 14,444 | 80,020 | 14,444 |